Bormioli Pharma Speeds Up on Innovation With H-FARM
Fast prototyping and an approach to innovation focused on customer needs are at the heart...
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for...
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information...
Invitae Corporation , a leading medical genetics company, announced it has entered into definitive agreements...
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that...
Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD
Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators,...
Beijing University of Chinese Medicine collaborates with Elsevier to launch first branch of traditional...
Elsevier, a global leader in information analytics, specializing in science and health, launched the first...
Biocair to participate in cell and gene webinar to explore ongoing material sourcing challenges
Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, will explore ongoing material...
Bactiguard Holding AB has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical...
Bactiguard Holding AB has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies...
Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline
Gilead Sciences Inc (GILD.O) said it would buy Forty Seven Inc (FTSV.O) for $4.9 billion...
Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic...
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced U.S. FDA...